Skip to content
PubMed This is a summary of 25 peer-reviewed journal articles Updated
Hematology

Life with Hb Lepore: Long-Term Surveillance and Wellness

At a Glance

People with Hb Lepore syndrome need individualized lifelong follow-up because transfusions and iron overload can affect the heart, liver, hormones, bones, blood sugar, pregnancy, and emotional health. Regular testing helps identify problems early.

Living with Hemoglobin Lepore-beta-thalassemia syndrome is a marathon, not a sprint. Because this condition and its treatments affect multiple organ systems over time, long-term health depends on a proactive “surveillance” schedule [1]. This means getting specific tests even when you feel perfectly fine, allowing your care team to catch and treat complications like iron overload or bone loss before they cause symptoms [2][3]. There is no “one-size-fits-all” schedule; your hematologist will customize the frequency of your MRI scans, bone density scans (DEXA), and lab work based on your age, transfusion status, and iron burden.

The Endocrine and Bone Health Checklist

Excess iron has a “preference” for the endocrine glands (which control your hormones) and the bone marrow [4].

  • Thyroid Function: Doctors should measure both TSH and Free T4 together. In thalassemia, iron can sometimes damage the pituitary gland, leading to “central” hypothyroidism where the TSH level appears falsely normal even though thyroid hormone is dangerously low [5][6].
  • Bone Density (DEXA): Many adults with the syndrome experience “thinning” of the bones [7]. Regular DEXA scans help monitor for osteoporosis. If you have a history of back pain, your doctor may also order imaging to check for “silent” vertebral fractures [8].
  • Calcium and Vitamin D: Because the parathyroid glands can be damaged by iron, leading to asymptomatic hypoparathyroidism, labs should periodically include calcium, phosphate, PTH, and Vitamin D levels [9][10].

Diabetes Screening: Why HbA1c Can Be Misleading

In the general population, an HbA1c blood test is the standard for screening for diabetes. However, in patients with Hb Lepore syndrome, this test can sometimes be unreliable [11].

  • The Problem: If you have significant hemolysis (red blood cells breaking down quickly) or if you receive regular blood transfusions, the HbA1c test may show a “normal” result even if your blood sugar is dangerously high [11][12].
  • The Solution: Many specialists prefer to use a fasting plasma glucose test or a 2-hour Oral Glucose Tolerance Test (OGTT) instead [13][14]. Some centers may also use Glycated Albumin or Continuous Glucose Monitoring (CGM) to get an accurate picture of your sugar levels.

Reproductive Health and Family Planning

If you are considering having children, meticulous preconception planning with a high-risk obstetrician and your hematologist is essential [15].

  • Preconception Health: Iron overload can affect the hormones needed for puberty and conception. Before pregnancy, you will need a thorough review of your cardiac iron, liver iron, and endocrine function [16][17].
  • Genetic Counseling: Because Hb Lepore is a rare structural variant, your partner should undergo hemoglobinopathy screening, followed by targeted molecular testing if necessary. A genetic counselor will help you understand the risks of passing on the trait or the syndrome [18][19].
  • Pregnancy Management: During pregnancy, your transfusion plan will be highly individualized to support fetal growth and protect your heart. Chelation therapy requires expert management: deferasirox and deferiprone are generally avoided, while deferoxamine is sometimes carefully used later in pregnancy if severe cardiac iron makes stopping dangerous [20][21]. Never change your chelation medications during pregnancy without your specialist’s strict oversight.

The Emotional “Weight” of Care

The psychosocial burden of a chronic blood disorder is significant. Adults with thalassemia report higher rates of anxiety and depression compared to the general population [22][23].

  • Treatment Burden: Many patients describe the time spent in clinics, the side effects of chelation, and the cycle of feeling tired before a transfusion as a heavy mental load [23].
  • Social Support: Chronic disease can lead to feelings of isolation [24]. Integrating mental health support into your routine care is a recognized and vital part of the international standard of care for thalassemia [25][22]. Finding a care center where clinicians understand the unique challenges of Hb Lepore can significantly improve your quality of life [24].

Common questions in this guide

Why do people with Hb Lepore syndrome need long-term monitoring?
Hb Lepore syndrome and its treatments can affect several organ systems over time, sometimes before symptoms appear. A personalized schedule of blood tests, MRI scans, and bone density scans can help the care team detect iron overload, bone loss, and hormone problems early.
Can I rely on an HbA1c test to screen for diabetes with Hb Lepore syndrome?
Not always. Hemolysis and regular blood transfusions can make HbA1c look normal even when blood sugar is high. Fasting plasma glucose or a two-hour oral glucose tolerance test may give a more reliable result, and some centers use glycated albumin or continuous glucose monitoring.
Which tests check thyroid, calcium, and bone health?
Thyroid testing should include both TSH and free T4 because iron-related pituitary damage can make TSH appear normal despite low thyroid hormone. Follow-up may also include a DEXA scan, calcium, phosphate, parathyroid hormone, and vitamin D testing. New back or bone pain may require imaging for vertebral fractures.
What health checks are needed before trying to become pregnant?
Before pregnancy, meet with your hematologist and a high-risk obstetrician to review heart iron, liver iron, and endocrine function. Your partner should have hemoglobinopathy screening, and genetic counseling can explain the chances of passing on a hemoglobin variant or syndrome.
How might iron chelation change during pregnancy?
Deferasirox and deferiprone are generally avoided during pregnancy. Deferoxamine may sometimes be considered later in pregnancy when severe cardiac iron makes stopping treatment dangerous. Never start, stop, or change chelation medicine without close guidance from your specialist.
What support can help with the emotional burden of Hb Lepore syndrome?
People with thalassemia may experience anxiety, depression, isolation, or stress related to clinic visits, chelation, and transfusions. Mental health care, patient support groups, and a treatment center familiar with thalassemia can help support quality of life.

Get notified when new evidence is published on Hemoglobin Lepore-beta-thalassemia syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (25)
  1. 1

    2021 Thalassaemia International Federation Guidelines for the Management of Transfusion-dependent Thalassemia.

    Farmakis D, Porter J, Taher A, et al.

    HemaSphere 2022; (6(8)):e732 doi:10.1097/HS9.0000000000000732.

    PMID: 35928543
  2. 2

    Prevalence of endocrine disorders and their associated factors in transfusion-dependent thalassemia patients: a historical cohort study in Southern Iran.

    Bordbar M, Bozorgi H, Saki F, et al.

    Journal of endocrinological investigation 2019; (42(12)):1467-1476 doi:10.1007/s40618-019-01072-z.

    PMID: 31228105
  3. 3

    International Consensus Guideline on the Diagnosis and Management of Endocrine Complications of β and α Thalassemia in Children and Adolescents.

    Habeb A, Deeb A, Hamza RT, et al.

    Hormone research in paediatrics 2026; (99(7)):931-954 doi:10.1159/000546904.

    PMID: 40555215
  4. 4

    Prevalence and risk factors predisposing low bone mineral density in patients with thalassemia.

    Ananvutisombat N, Tantiworawit A, Punnachet T, et al.

    Frontiers in endocrinology 2024; (15()):1393865 doi:10.3389/fendo.2024.1393865.

    PMID: 38978629
  5. 5

    High prevalence of central hypothyroidism among patients with transfusion dependent thalassemia in Hospital Pulau Pinang: A cross sectional study.

    Seow CE, Goh AS, Lim SL

    The Medical journal of Malaysia 2021; (76(6)):799-803.

    PMID: 34806663
  6. 6

    Thyroid Disorders in Homozygous β-Thalassemia: Current Knowledge, Emerging Issues and Open Problems.

    De Sanctis V, Soliman AT, Canatan D, et al.

    Mediterranean journal of hematology and infectious diseases 2019; (11(1)):e2019029 doi:10.4084/MJHID.2019.029.

    PMID: 31205633
  7. 7

    Prevalence and risk factors of fractures in transfusion dependent thalassemia - A Hong Kong Chinese population cohort.

    Lee SLK, Wong RSM, Li CK, Leung WK

    Endocrinology, diabetes & metabolism 2022; (5(4)):e340 doi:10.1002/edm2.340.

    PMID: 35490138
  8. 8

    The Trabecular Bone Score as a Predictor for Thalassemia-Induced Vertebral Fractures in Northeastern Thailand.

    Teawtrakul N, Chukanhom S, Charoensri S, et al.

    Anemia 2020; (2020()):4634709 doi:10.1155/2020/4634709.

    PMID: 32774916
  9. 9

    Vitamin D deficiency and its relationship with cardiac iron and function in patients with transfusion-dependent thalassemia at Chiang Mai University Hospital.

    Dejkhamron P, Wejaphikul K, Mahatumarat T, et al.

    Pediatric hematology and oncology 2018; (35(1)):52-59 doi:10.1080/08880018.2018.1424280.

    PMID: 29359982
  10. 10

    Under-recognized Hypoparathyroidism in Thalassemia

    Tangngam H, Mahachoklertwattana P, Poomthavorn P, et al.

    Journal of clinical research in pediatric endocrinology 2018; (10(4)):324-330 doi:10.4274/jcrpe.0020.

    PMID: 29726397
  11. 11

    For Debate: Assessment of HbA1c in Transfusion Dependent Thalassemia Patients.

    De Sanctis V, Soliman AT, Daar S, et al.

    Pediatric endocrinology reviews : PER 2020; (17(3)):226-234 doi:10.17458/per.vol17.2020.fd.ssd.HbA1cthalassemia.

    PMID: 32741153
  12. 12

    Compound heterozygous with Hb G-Taipei and Hb Lepore-Boston-Washington: An unexpected finding triggered by HbA1c measurement.

    Li Y, Xu A, He J, et al.

    Practical laboratory medicine 2024; (39()):e00379 doi:10.1016/j.plabm.2024.e00379.

    PMID: 38715657
  13. 13

    Estimation of HbA1c Levels in Transfusion-Dependent Thalassemia Patients in Comparison With Normal Healthy Individuals.

    Bhatti PK, Ghay R, Singh Narang G, et al.

    Cureus 2024; (16(11)):e73236 doi:10.7759/cureus.73236.

    PMID: 39651019
  14. 14

    A Multicenter ICET-A Survey on Adherence to Annual Oral Glucose Tolerance Test (OGTT) Screening in Transfusion-Dependent Thalassemia (TDT) Patients - The Expert Clinicians' Opinion on Factors Influencing the Adherence and on Alternative Strategies for Adherence Optimization.

    de Sanctis V, Canatan D, Daar S, et al.

    Mediterranean journal of hematology and infectious diseases 2025; (17(1)):e2025008 doi:10.4084/MJHID.2025.008.

    PMID: 39830799
  15. 15

    Fertility and Pregnancy in Women with Transfusion-Dependent Thalassemia.

    Sayani FA, Singer ST, Carlberg KT, Vichinsky EP

    Hematology/oncology clinics of North America 2023; (37(2)):393-411 doi:10.1016/j.hoc.2022.12.008.

    PMID: 36907611
  16. 16

    Desire for biological parenthood and patient counseling on the risk of infertility among adolescents and adults with hemoglobinopathies.

    Radauer-Plank AC, Diesch-Furlanetto T, Schneider M, et al.

    Pediatric blood & cancer 2023; (70(7)):e30359 doi:10.1002/pbc.30359.

    PMID: 37057367
  17. 17

    Fertility and pregnancy in Iranian thalassemia patients: An update on transfusion complications.

    Takhviji V, Zibara K, Azarkeivan A, et al.

    Transfusion medicine (Oxford, England) 2020; (30(5)):352-360 doi:10.1111/tme.12707.

    PMID: 32820581
  18. 18

    Invasive prenatal diagnosis of fetal thalassemia.

    Li DZ, Yang YD

    Best practice & research. Clinical obstetrics & gynaecology 2017; (39()):41-52 doi:10.1016/j.bpobgyn.2016.10.011.

    PMID: 27889305
  19. 19

    Carrier Screening Programs for Cystic Fibrosis, Fragile X Syndrome, Hemoglobinopathies and Thalassemia, and Spinal Muscular Atrophy: A Health Technology Assessment.

    Ontario health technology assessment series 2023; (23(4)):1-398.

    PMID: 37637488
  20. 20

    Transfusion Management in Pregnancies Complicated by Hemoglobinopathies: Evidence, Guidelines, and Clinical Challenges.

    Delicou S, Xydaki A, Moraki M, et al.

    Maternal-fetal medicine (Wolters Kluwer Health, Inc.) 2026; (8(4)):406-416 doi:10.1097/FM9.0000000000000353.

    PMID: 42936835
  21. 21

    Pregnancy outcomes and iron status in β-thalassemia major and intermedia: a systematic review and meta-analysis.

    Vlachodimitropoulou E, Mogharbel H, Kuo KHM, et al.

    Blood advances 2024; (8(3)):746-757 doi:10.1182/bloodadvances.2023011636.

    PMID: 38181780
  22. 22

    The burden of psychiatric illnesses in adult patients with beta-thalassemia: a 5-year nationwide inpatient evaluation in the United States.

    Patel K, Bhivandkar S, Desai R, Antin T

    Annals of hematology 2019; (98(4)):851-860 doi:10.1007/s00277-018-3557-5.

    PMID: 30488326
  23. 23

    Understanding the Association between Red Blood Cell Transfusion Utilization and Humanistic and Economic Burden in Patients with β-Thalassemia from the Patients' Perspective.

    Knoth RL, Gupta S, Perkowski K, et al.

    Journal of clinical medicine 2023; (12(2)) doi:10.3390/jcm12020414.

    PMID: 36675342
  24. 24

    Health-Related Quality-of-Life Impacts Associated with Transfusion-Dependent β-Thalassemia in the USA and UK: A Qualitative Assessment.

    Drahos J, Boateng-Kuffour A, Calvert M, et al.

    The patient 2024; (17(4)):421-439 doi:10.1007/s40271-024-00678-7.

    PMID: 38530509
  25. 25

    Quality of Life and Related Paraclinical Factors in Iranian Patients with Transfusion-Dependent Thalassemia.

    Khodashenas M, Mardi P, Taherzadeh-Ghahfarokhi N, et al.

    Journal of environmental and public health 2021; (2021()):2849163 doi:10.1155/2021/2849163.

    PMID: 34457009

This page is for informational purposes only and does not constitute medical advice. Your hematologist and other specialists should tailor surveillance, pregnancy, and treatment decisions to your health.